Research menu
Jump to menu

Publications:  Prof Kairbaan Hodivala-Dilke

Lechertier T, Reynolds LE, Kim H, Pedrosa AR, Gómez-Escudero J, Muñoz-Félix JM, Batista S, Dukinfield M et al.(2020). Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth. Nature Communications vol. 11, (1)
Roy-Luzarraga M, Abdel-Fatah T, Reynolds LE, Clear A, Taylor JG, Gribben JG, Chan S, Jones L et al.(2020). Association of Low Tumor Endothelial Cell pY397-Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer. JAMA network open vol. 3, (10)
Abdul Pari AA, Singhal M, Hübers C, Mogler C, Schieb B, Gampp A, Gengenbacher N, Reynolds LE et al.(2020). Tumor Cell-Derived Angiopoietin-2 Promotes Metastasis in Melanoma. Cancer Res vol. 80, (12) 2586-2598.
Wong PP, Muñoz-Félix JM, Hijazi M, Kim H, Robinson SD, De Luxán-Delgado B, Rodríguez-Hernández I, Maiques O et al.(2020). Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells. Cell vol. 181, (6) 1346-1363.e21.
Demircioglu F, Wang J, Candido J, Costa ASH, Casado P, de Luxan Delgado B, Reynolds LE, Gomez-Escudero J et al.(2020). Cancer associated fibroblast FAK regulates malignant cell metabolism. Nature Communications vol. 11, (1) 1290-1290.
Moyes AJ, Chu SM, Aubdool AA, Dukinfield MS, Margulies KB, Bedi KC, Hodivala-Dilke K, Baliga RS et al.(2020). C-type natriuretic peptide co-ordinates cardiac structure and function. European Heart Journal vol. 41, (9) 1006-1020.
Wilcz-Villega E, Carter E, Ironside A, Xu R, Mataloni I, Holdsworth J, Jones W, Moreno Béjar R et al.(2020). Macrophages induce malignant traits in mammary epithelium via IKKε/TBK1 kinases and the serine biosynthesis pathway. EMBO Molecular Medicine vol. 12, (2)
D'Amico G, Muñoz-Félix JM, Pedrosa AR, Hodivala-Dilke KM(2020). “Splitting the matrix”: intussusceptive angiogenesis meets MT1-MMP. EMBO Molecular Medicine vol. 12, (2)
Li J, Fukase Y, Shang Y, Zou W, Muñoz-Félix JM, Buitrago L, Van Agthoven J, Zhang Y et al.(2019). Novel Pure αvβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations. ACS Pharmacology and Translational Science vol. 2, (6) 387-401.
Dukinfield M, Maniati E, Reynolds LE, Aubdool A, Baliga RS, D'Amico G, Maiques O, Wang J et al.(2019). Repurposing an anti-cancer agent for the treatment of hypertrophic heart disease. Journal of Pathology vol. 249, (4) 523-535.
Pedrosa A-R, BODRUG N, Gomez-Escudero J, Carter EP, Reynolds LE, Georgiou PN, Fernandez I, Lees DM et al.(2019). Tumour angiogenesis is differentially regulated by endothelial cell Focal Adhesion Kinase tyrosine-397 and -861 phosphorylation. Cancer Research
Li Z, Solomonidis EG, Meloni M, Taylor RS, Duffin R, Dobie R, Magalhaes MS, Henderson BEP et al.(2019). Single-cell transcriptome analyses reveal novel targets modulating cardiac neovascularization by resident endothelial cells following myocardial infarction. European Heart Journal vol. 40, (30) 2507-2520.
Foxler DE, Bridge KS, Foster JG, Grevitt P, Curry S, Shah KM, Davidson KM, Nagano A et al.(2018). A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxia. EMBO Mol Med
Weinmüller M, Rechenmacher F, Kiran Marelli U, Reichart F, Kapp TG, Räder AFB, Di Leva FS, Marinelli L et al.(2017). Overcoming the Lack of Oral Availability of Cyclic Hexapeptides: Design of a Selective and Orally Available Ligand for the Integrin αvβ3. Angewandte Chemie - International Edition vol. 56, (51) 16405-16409.
Alexopoulou AN, Lees DM, Bodrug N, Lechertier T, Fernandez I, D'Amico G, Dukinfield M, Batista S et al.(2017). Focal Adhesion Kinase (FAK) tyrosine 397E mutation restores the vascular leakage defect in endothelium-specific FAK-kinase dead mice. Journal of Pathology vol. 242, (3) 358-370.
Ross JA, Webster RG, Lechertier T, Reynolds LE, Turmaine M, Bencze M, Jamshidi Y, Cetin H et al.(2017). Multiple roles of integrin-α3 at the neuromuscular junction. J Cell Sci vol. 130, (10) 1772-1784.
Reynolds LE, D'Amico G, Lechertier T, Papachristodoulou A, Muñoz-Félix JM, DeArcangelis A, Baker M, Serrels B et al.(2017). Dual role of pericyte α6β1-integrin in tumour blood vessels. Journal of Cell Science vol. 130, (9) 1583-1595.
(2017). Correction: A Promyelocytic Leukemia Protein-Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma. Clin Cancer Res vol. 23, (3)
Rudran B, Desai A, Luzarraga M, Hodivala-Dilke K, Foster J, Sosabowski J, Marshall J (2017). Development of non-invasive imaging of integrin alpha-v-beta-6 (alpha v beta 6)-positive lung cancers in advance of testing alpha v beta 6-targeted therapies. Lung Cancer. Conference: British Thoracic Oncology Group Conference 2017 (Dublin, Ireland) from: 25/01/2017 to: 27/01/2017, vol. 103, S4-S4.
Wong PP, Bodrug N, Hodivala-Dilke KM(2016). Exploring Novel Methods for Modulating Tumor Blood Vessels in Cancer Treatment. Current Biology vol. 26, (21) R1161-R1166.
Demircioglu F, Hodivala-Dilke K(2016). αvβ3 Integrin and tumour blood vessels — learning from the past to shape the future. Current Opinion in Cell Biology vol. 42, 121-127.
Roy-Luzarraga M, Hodivala-Dilke K(2016). Molecular Pathways: Endothelial Cell FAK--A Target for Cancer Treatment. Clinical Cancer Research vol. 22, (15) 3718-3724.
Di Maggio F, Arumugam P, Delvecchio FR, Batista S, Lechertier T, Hodivala-Dilke K, Kocher HM(2016). Pancreatic stellate cells regulate blood vessel density in the stroma of pancreatic ductal adenocarcinoma. Pancreatology
Dvorkina M, Nieddu V, Chakelam S, Pezzolo A, Cantilena S, Leite AP, Chayka O, Regad T et al.(2016). A promyelocytic leukemia protein-thrombospondin 2 axis and the risk of relapse in neuroblastoma. Clinical Cancer Research
Martins VL, Caley MP, Moore K, Szentpetery Z, Marsh ST, Murrell DF, Kim MH, Avari M et al.(2015). Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC. J Natl Cancer Inst vol. 108, (1)
Ross J, Webster R, Lechertier T, Reynolds L, Muntoni F, Beeson D, Hodivala-Dilke K, Conti F (2015). G.O.9 Integrins are required for synaptic transmission and development of the neuromuscular junction. Neuromuscular Disorders. vol. 25,
Gopinathan G, Milagre C, Pearce OMT, Reynolds L, Hodivala-Dilke K, Leinster A, Zhong H, Hollingsworth RE et al.(2015). Abstract 4162: Interleukin–6 stimulates defective angiogenesis. 4162-4162.
Gopinathan G, Milagre C, Pearce OMT, Reynolds LE, Hodivala-Dilke K, Leinster DA, Zhong H, Hollingsworth RE et al.(2015). Interleukin-6 stimulates defective angiogenesis. Cancer Research vol. 75, (15) 3098-3107.
Wong PP, Demircioglu F, Ghazaly E, Alrawashdeh W, Stratford MRL, Scudamore CL, Cereser B, Crnogorac-Jurcevic T et al.(2015). Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread. Cancer Cell vol. 27, (1) 123-137.
Wong P-P, Demircioglu F, Ghazaly E, Alrawashdeh W, Stratford M, Scudamore C, Cereser B, Crnogorac-Jurcevic T et al. (2015). NOVEL DUAL-ACTION COMBINATION THERAPY ENHANCES ANGIOGENESIS WHILST REDUCING TUMOR GROWTH AND SPREAD. JOURNAL OF VASCULAR RESEARCH. vol. 52, 6-6.
Birdsey GM, Shah AV, Dufton N, Reynolds LE, Almagro LO, Yang Y, Aspalter IM, Khan ST et al.(2015). The endothelial transcription factor erg promotes vascular stability and growth through Wnt/β-catenin signaling. Developmental Cell vol. 32, (1) 82-96.
Browne AK, Tookman LA, Ingemarsdotter CK, Bouwman R, Pirlo K, Wang Y, Hodivala-Dilke KM, McNeish IA et al. (2014). 106 Beta-3 integrin inhibition reduces inflammatory cytokine release but not anti-cancer activity of oncolytic adenovirus in ovarian cancer. European Journal of Cancer. vol. 50,
Tavora B, Batista S, Alexopoulou AN, Kostourou V, Fernandez I, Robinson SD, Lees DM, Serrels B et al.(2014). Generation of point-mutant FAK knockin mice. Genesis vol. 52, (11) 907-915.
Tavora B, Reynolds LE, Batista S, Demircioglu F, Fernandez I, Lechertier T, Lees DM, Wong P-P et al.(2014). Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy. Nature vol. 514, (7520) 112-116.
Batista S, Maniati E, Reynolds LE, Tavora B, Lees DM, Fernandez I, Elia G, Casanovas O et al.(2014). Haematopoietic focal adhesion kinase deficiency alters haematopoietic homeostasis to drive tumour metastasis. Nat Commun vol. 5,
Shah AV, Birdsey GM, Reynolds LE, Dufton N, Almagro LO, Yang Y, Aspalter IM, Khan ST et al.(2014). The endothelial transcription factor ERG promotes vascular stability and growth through Wnt/beta-catenin signaling. ANGIOGENESIS vol. 17, (3) 715-715.
Moore AD, Hodgkinson C, Lapenna A, Zhang F, Witkowska K, Liang Ng F, Headland SE, Reynolds L et al. (2014). 203 Hypoxia-inducible Factor-1 Regulates Matrix Metalloproteinase-14 Expression: Underlying Effects of Hypoxia and Statins. Heart. vol. 100 Suppl 3, A111-A112.
Alexopoulou AN, Ho-Yen CM, Papalazarou V, Elia G, Jones JL, Hodivala-Dilke K(2014). Tumour-associated endothelial-FAK correlated with molecular sub-type and prognostic factors in invasive breast cancer. BMC Cancer vol. 14,
Steri V, Ellison TS, Gontarczyk AM, Weilbaecher K, Schneider JG, Edwards D, Fruttiger M, Hodivala-Dilke KM et al.(2014). Acute depletion of endothelial β3-integrin transiently inhibits tumor growth and angiogenesis in mice. Circulation Research vol. 114, (1) 79-91.
Martino-Echarri E, Fernández-Rodríguez R, Rodríguez-Baena FJ, Barrientos-Durán A, Torres-Collado AX, Plaza-Calonge MDC, Amador-Cubero S, Cortés J et al.(2013). Contribution of ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on nidogen-1 and nidogen-2. Int J Cancer vol. 133, (10) 2315-2324.
Fokas E, Lechterier T, Hackl W, S-M M, McKenna WG, Hodivala-Dilke K, Muschel RJ (2013). Dose- and schedule-dependent changes in vascular morphology after PI3K and PI3K/mTOR inhibition: in vitro vs. in vivo effects. STRAHLENTHERAPIE UND ONKOLOGIE. vol. 189, 41-41.
Jones DT, Lechertier T, Reynolds LE, Mitter R, Robinson SD, Kirn-Safran CB, Hodivala-Dilke KM(2013). Endogenous ribosomal protein L29 (RPL29): a newly identified regulator of angiogenesis in mice. Dis Model Mech vol. 6, (1) 115-124.
Kostourou V, Lechertier T, Reynolds LE, Lees DM, Baker M, Jones DT, Tavora B, Ramjaun AR et al.(2013). FAK-heterozygous mice display enhanced tumour angiogenesis. Nat Commun vol. 4,
Ma Y, Reynolds LE, Li A, Stevenson RP, Hodivala-Dilke KM, Yamashiro S, Machesky LM(2013). Fascin 1 is dispensable for developmental and tumour angiogenesis. Biol Open vol. 2, (11) 1187-1191.
Baker M, Reynolds LE, Robinson SD, Lees DM, Parsons M, Elia G, Hodivala-Dilke K(2013). Stromal Claudin14-heterozygosity, but not deletion, increases tumour blood leakage without affecting tumour growth. PLoS One vol. 8, (5)
Dreger SA, Payne SJ, Dawoud M, Robinson SD, Marshall JF, Hodivala-Dilke KM, Allen MD, Jones JL (2012). Up-regulation of alpha v beta 6 integrin and fibronectin EDA in myoepithelial cells contribute to the angiogenic switch in pre-invasive breast cancer. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. vol. 93, A24-A24.
Ross J, Lechertier T, Morgan J, Muntoni F, Hodivala-Dilke K, Conti F (2012). Roles of alpha 3-integrin in development of the neuromuscular system. NEUROMUSCULAR DISORDERS. vol. 22, S11-S11.
Lechertier T, Hodivala-Dilke K(2012). Focal adhesion kinase and tumour angiogenesis. J Pathol vol. 226, (2) 404-412.
Jones DT, Lechertier T, Mitter R, Herbert JMJ, Bicknell R, Jones JL, Li J-L, Buffa F et al.(2012). Gene expression analysis in human breast cancer associated blood vessels. PLoS One vol. 7, (10)
Baker M, Robinson SD, Lechertier T, Barber PR, Tavora B, D'Amico G, Jones DT, Vojnovic B et al.(2011). Use of the mouse aortic ring assay to study angiogenesis. Nat Protoc vol. 7, (1) 89-104.
Robinson SD, Hodivala-Dilke KM(2011). The role of β3-integrins in tumor angiogenesis: context is everything. Curr Opin Cell Biol vol. 23, (5) 630-637.
Tavora B, Hodivala-dilke K (2011). Abstract 3472: Endothelial FAK is required for tumor angiogenesis. 3472-3472.
Baker M, Robinson SD, Hodivala-Dilke K, Ben-Yosef T(2011). Abstract 3479: Claudin-14: A novel regulator of angiogenesis. 3479-3479.
Jones DT, Lechertier T, Herbert J, Bicknell R, Jones LJ, Harris AL, Hodivala-Dilke K (2011). Abstract 4848: Genetic profile of invasive breast cancer vasculature using laser capture microdissection (LCM) to capture vessels. 4848-4848.
Batista SA, Reynolds L, Tavora B, Hodivala-Dilke K(2011). Abstract 517: Deficiency of FAK in the bone marrow compartment enhances tumour metastasis. 517-517.
Hodivala-Dilke KM(2011). Abstract SY16-03: Dose matters and angiogenesis.
Hodivala-Dilke KM(2011). Dose matters and angiogenesis. CANCER RESEARCH vol. 71,
Tavora B, Batista S, Hodivala-Dilke K(2011). Measuring angiogenesis in mice. Methods Mol Biol vol. 769, 351-358.
Tavora B, Batista S, Reynolds LE, Jadeja S, Robinson S, Kostourou V, Hart I, Fruttiger M et al.(2010). Endothelial FAK is required for tumour angiogenesis. EMBO Mol Med vol. 2, (12) 516-528.
da Silva RG, Tavora B, Robinson SD, Reynolds LE, Szekeres C, Lamar J, Batista S, Kostourou V et al.(2010). Endothelial alpha3beta1-integrin represses pathological angiogenesis and sustains endothelial-VEGF. Am J Pathol vol. 177, (3) 1534-1548.
Reynolds LE, Watson AR, Baker M, Jones TA, D'Amico G, Robinson SD, Joffre C, Garrido-Urbani S et al.(2010). Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome (Corrigendum). NATURE vol. 466, (7304)
Reynolds LE, Watson AR, Baker M, Jones TA, D'Amico G, Robinson SD, Joffre C, Garrido-Urbani S et al.(2010). Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome. Nature vol. 465, (7299) 813-817.
Worth DC, Hodivala-Dilke K, Robinson SD, King SJ, Morton PE, Gertler FB, Humphries MJ, Parsons M(2010). Alpha v beta3 integrin spatially regulates VASP and RIAM to control adhesion dynamics and migration. J Cell Biol vol. 189, (2) 369-383.
D'Amico G, Robinson SD, Germain M, Reynolds LE, Thomas GJ, Elia G, Saunders G, Fruttiger M et al.(2010). Endothelial-Rac1 is not required for tumor angiogenesis unless alphavbeta3-integrin is absent. PLoS One vol. 5, (3)
Watson AR, Pitchford SC, Reynolds LE, Direkze N, Brittan M, Alison MR, Rankin S, Wright NA et al.(2010). Deficiency of bone marrow beta3-integrin enhances non-functional neovascularization. J Pathol vol. 220, (4) 435-445.
Germain M, De Arcangelis A, Robinson SD, Baker M, Tavora B, D'Amico G, Silva R, Kostourou V et al.(2010). Genetic ablation of the alpha 6-integrin subunit in Tie1Cre mice enhances tumour angiogenesis. J Pathol vol. 220, (3) 370-381.
D'Amico G, Jones DT, Nye E, Sapienza K, Ramjuan AR, Reynolds LE, Robinson SD, Kostourou V et al.(2010). Regulation of lymphatic-blood vessel separation by endothelial Rac1 (vol 136, pg 4043, 2009). DEVELOPMENT vol. 137, (2) 359-359.
Dawoud MM, Jones D, Hodivala-Dilke K, Dreger S, Chelala C, Asaad NY, Jones L (2009). Microenvironmental Changes in DCIS: Myoepithelial Cells Change from Tumour Suppressor to Tumour Promoter. CANCER RESEARCH. vol. 69, 760S-760S.
Robinson SD, Reynolds LE, Kostourou V, Reynolds AR, da Silva RG, Tavora B, Baker M, Marshall JF et al.(2009). Alphav beta3 integrin limits the contribution of neuropilin-1 to vascular endothelial growth factor-induced angiogenesis. J Biol Chem vol. 284, (49) 33966-33981.
D'Amico G, Jones DT, Nye E, Sapienza K, Ramjuan AR, Reynolds LE, Robinson SD, Kostourou V et al.(2009). Regulation of lymphatic-blood vessel separation by endothelial Rac1. Development vol. 136, (23) 4043-4053.
Reynolds AR, Hodivala-Dilke KM(2009). Will integrin inhibitors have proangiogenic effects in the clinic? Reply. NAT MED vol. 15, (7) 727-727.
Reynolds AR, Hart IR, Watson AR, Welti JC, Silva RG, Robinson SD, Da Violante G, Gourlaouen M et al.(2009). Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nat Med vol. 15, (4) 392-400.
Ramjaun AR, Hodivala-Dilke K(2009). The role of cell adhesion pathways in angiogenesis. Int J Biochem Cell Biol vol. 41, (3) 521-530.
Silva R, D'Amico G, Hodivala-Dilke KM, Reynolds LE(2008). Integrins - The keys to unlocking angiogenesis. ARTERIOSCL THROM VAS vol. 28, (10) 1703-1713.
Hodivala-Dilke K(2008). alpha v beta 3 integrin and angiogenesis: a moody integrin in a changing environment. CURR OPIN CELL BIOL vol. 20, (5) 514-519.
Schier S, Watson A, Hodivala-Dilke K, Wright NA(2008). The role of beta 3-integrin on bone marrow-derived cells in inflammatory bowel diseases. GASTROENTEROLOGY vol. 134, (4) A257-A257.
Reynolds LE, Conti FJ, Silva R, Robinson SD, Iyer V, Rudling R, Cross B, Nye E et al.(2008). alpha3beta1 integrin-controlled Smad7 regulates reepithelialization during wound healing in mice. J Clin Invest vol. 118, (3) 965-974.
Claxton S, Kostourou V, Jadeja S, Chambon P, Hodivala-Dilke K, Fruttiger M(2008). Efficient, inducible Cre-recombinase activation in vascular endothelium. GENESIS vol. 46, (2) 74-80.
Scott AN, Hetheridge C, Reynolds AR, Nayak V, Hodivala-Dilke K, Mellor H(2008). Farnesyltransferase inhibitors target multiple endothelial cell functions in angiogenesis. Angiogenesis vol. 11, (4) 337-346.
Boosani CS, Mannam AP, Cosgrove D, Silva R, Hodivala-Dilke KM, Keshamouni VG, Sudhakar A(2007). Regulation of COX-2-mediated signaling by alpha 3 type IV noncollagenous domain in tumor angiogenesis. BLOOD vol. 110, (4) 1168-1177.
Piqueras L, Reynolds AR, Hodivala-Dilke KM, Alfranca A, Redondo JM, Hatae T, Tanabe T, Warner TD et al.(2007). Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis. Arterioscler Thromb Vasc Biol vol. 27, (1) 63-69.
Lucas M, Stuart LM, Zhang A, Hodivala-Dilke K, Febbraio M, Silverstein R, Savill J, Lacy-Hulbert A(2006). Requirements for apoptotic cell contact in regulation of macrophage responses. J IMMUNOL vol. 177, (6) 4047-4054.
Direkze NC, Jeffery R, Hodivala-Dilke K, Burke F, Hunt FT, Poulsom R, Balkwill F, Wright NA et al. (2006). Bone marrow contributes to functionally active cells in tumour stroma. JOURNAL OF PATHOLOGY. vol. 210, 1-1.
Hodivala-Dilke KM, Reynolds L, Reynolds A, Robinson S, Wyder L, Lively J, Taverna D, Hynes R et al. (2006). Evaluating the role of b3-integrins in angiogenesis. FASEB JOURNAL. vol. 20, A22-A22.
Direkze NC, Jeffery R, Hodivala-Dilke K, Hunt T, Playford RJ, Elia G, Poulsom R, Wright NA et al.(2006). Bone marrow-derived stromal cells express lineage-related messenger RNA species. Cancer Res vol. 66, (3) 1265-1269.
Robinson SD, Wilson S, Hodivala-Dilke KM(2006). Generation of genetically modified embryonic stem cells for the development of knockout mouse animal model systems. Methods Mol Med vol. 120, 465-477.
Germain M, Silva R, Reynolds L, Robinson S, DiPersio M, Kreidberg J, Georges-Labouesse E, Hodivala-Dilke K (2006). Novel roles for integrins in tumour angiogenesis. BREAST CANCER RESEARCH. vol. 8, S3-S3.
Reynolds LE, Hodivala-Dilke KM(2006). Primary mouse endothelial cell culture for assays of angiogenesis. Methods Mol Med vol. 120, 503-509.
Fang J, Hodivala-Dilke K, Johnson BD, Du LM, Hynes RO, White GC, Wilcox DA(2005). Therapeutic expression of the platelet-specific integrin, alpha IIb beta 3, in a murine model for Glanzmann thrombasthenia. BLOOD vol. 106, (8) 2671-2679.
Lamagna C, Hodivala-Dilke KM, Imhof BA, Aurrand-Lions M(2005). Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth. CANCER RES vol. 65, (13) 5703-5710.
Direkze N, Jeffery R, Hodivala-Dilke K, Burke F, Hunt T, Poulsom R, Alison M, Balkwill F et al. (2005). Bone marrow contributes functionally active cell types to tumour stroma. GASTROENTEROLOGY. vol. 128, A182-A182.
Direkze NC, Jeffery R, Hodivala-Dilke K, Burke F, Hunt FT, Poulsom R, Alison MR, Balkwill F et al. (2005). Bone marrow contributes to functionally active cells in tumour stroma. GUT. vol. 54, A24-A24.
Brittan M, Braun KM, Reynolds LM, Conti FJ, Reynolds AR, Poulsom R, Alison MR, Wright NA et al. (2005). Transplanted Bone marrow cells engraft within the mouse epidermis and proliferate with no evidence of cell fusion. JOURNAL OF PATHOLOGY. vol. 205, 6-6.
Reynolds LE, Conti FJ, Lucas M, Grose R, Robinson S, Stone M, Saunders G, Dickson C et al.(2005). Accelerated re-epithelialization in beta3-integrin-deficient- mice is associated with enhanced TGF-beta1 signaling. Nat Med vol. 11, (2) 167-174.
Brittan M, Braun KM, Reynolds LE, Conti FJ, Reynolds AR, Poulsom R, Alison MR, Wright NA et al.(2005). Bone marrow cells engraft within the epidermis and proliferate in vivo with no evidence of cell fusion. J Pathol vol. 205, (1) 1-13.
McLean GW, Komiyama NH, Serrels B, Asano H, Reynolds L, Conti F, Hodivala-Dilke K, Metzger D et al.(2004). Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. Genes Dev vol. 18, (24) 2998-3003.
Direkze NC, Hodivala-Dilke K, Jeffery R, Hunt T, Poulsom R, Oukrif D, Alison MR, Wright NA(2004). Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res vol. 64, (23) 8492-8495.
Reynolds AR, Reynolds LE, Nagel TE, Lively JC, Robinson SD, Hicklin DJ, Bodary SC, Hodivala-Dilke KM(2004). Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice. Cancer Res vol. 64, (23) 8643-8650.
Robinson SD, Reynolds LE, Wyder L, Hicklin DJ, Hodivala-Dilke KM(2004). Beta3-integrin regulates vascular endothelial growth factor-A-dependent permeability. Arterioscler Thromb Vasc Biol vol. 24, (11) 2108-2114.
Direkze NC, Hodivala-Dilke K, Jeffery R, Hunt T, Oukrif D, Preston SL, Alison MR, Wright NA (2004). Bone marrow contributes to tumour stroma. JOURNAL OF PATHOLOGY. vol. 204, 10A-10A.
Direkze NC, Hodivala-Dilke K, Jeffery R, Hunt T, Preston SL, Alison MR, Wright NA (2004). Bone marrow contributes to tumour stroma. GASTROENTEROLOGY. vol. 126, A134-A135.
Mistry A, Harbottle R, Hart S, Hodivala-Dilke KM(2003). Integrins and angiogenesis: unlocking the route to gene therapy. Curr Opin Mol Ther vol. 5, (6) 603-610.
Petiot A, Conti FJA, Grose R, Revest J-M, Hodivala-Dilke KM, Dickson C(2003). A crucial role for Fgfr2-IIIb signalling in epidermal development and hair follicle patterning. Development vol. 130, (22) 5493-5501.
Wan H, Stone MG, Simpson C, Reynolds LE, Marshall JF, Hart IR, Hodivala-Dilke KM, Eady RAJ(2003). Desmosomal proteins, including desmoglein 3, serve as novel negative markers for epidermal stem cell-containing population of keratinocytes. J Cell Sci vol. 116, (Pt 20) 4239-4248.
Alugupalli KR, Michelson AD, Joris I, Schwan TG, Hodivala-Dilke K, Hynes RO, Leong JM(2003). Spirochete-platelet attachment and thrombocytopenia in murine relapsing fever borreliosis. Blood vol. 102, (8) 2843-2850.
Hodivala-Dilke KM, Reynolds AR, Reynolds LE(2003). Integrins in angiogenesis: multitalented molecules in a balancing act. Cell Tissue Res vol. 314, (1) 131-144.
Direkze NC, Forbes SJ, Brittan M, Hunt T, Jeffery R, Preston SL, Poulsom R, Hodivala-Dilke K et al. (2003). Bone marrow derived cells contribute to a population of fibroblasts and myofibroblasts which engraft to multiple sites, including the gastrointestinal tract. JOURNAL OF PATHOLOGY. vol. 201, 6A-6A.
Conti FJA, Rudling RJ, Robson A, Hodivala-Dilke KM(2003). alpha3beta1-integrin regulates hair follicle but not interfollicular morphogenesis in adult epidermis. J Cell Sci vol. 116, (Pt 13) 2737-2747.
Wilcox DA, Hodivala-Dilke KM, Johnson BD, Hynes RO, White GC (2003). Therapeutic expression of a platelet-specific integrin, alpha IIb beta 3. MOLECULAR THERAPY. vol. 7, S157-S157.
Direkze NC, Forbes S, Brittan M, Hunt T, Jeffery R, Preston SL, Poulsom R, Hodivala-Dilke K et al. (2003). Bone marrow derived cells contribute to a population of fibroblasts and myofibroblasts which engraft to multiple sites, including the gastrointestinal tract. GUT. vol. 52, A50-A50.
Direkze NC, Forbes SJ, Brittan M, Hunt T, Jeffery R, Preston SL, Poulsom R, Hodivala-Dilke K et al.(2003). Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. Stem Cells vol. 21, (5) 514-520.
Reynolds AR, Moein Moghimi S, Hodivala-Dilke K(2003). Nanoparticle-mediated gene delivery to tumour neovasculature. Trends Mol Med vol. 9, (1) 2-4.
Jones SM, Hunt T, Brittan M, Jeffery R, Forbes S, Hodivala-Dilke K, Alison M, Wright N et al. (2002). Lung repair by haematopoietic stem cells (HSC) after bone marrow transplant (BMT). THORAX. vol. 57,
Wilcox DA, Hodivala-Dilke KM, Johnson BD, Hynes RO, White GC (2002). Lineage-specific correction of Glanzmann thrombasthenia by expression of a functional hybrid murine-human alpha IIb beta 3 integrin complex on the surface of platelets of beta 3-knockout mice. BLOOD. vol. 100, 867A-867A.
Wan H, Marshall J, Reynolds LE, Stone MG, McGrath JA, Hodivala-Dilke KM, Eady RAJ(2002). Diversity of desmoplakin expression in basal palm keratinocytes: A possible clue to the identification of epidermal stem cells. J INVEST DERMATOL vol. 119, (3) 714-714.
Schulz O, Pennington DJ, Hodivala-Dilke K, Febbraio M, Reis e Sousa C(2002). CD36 or alphavbeta3 and alphavbeta5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8 alpha+ murine dendritic cells. J Immunol vol. 168, (12) 6057-6065.
Brittan M, Hunt T, Jeffery R, Poulsom R, Forbes SJ, Hodivala-Dilke K, Goldman J, Alison MR et al.(2002). Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut vol. 50, (6) 752-757.
Francis SE, Goh KL, Hodivala-Dilke K, Bader BL, Stark M, Davidson D, Hynes RO(2002). Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler Thromb Vasc Biol vol. 22, (6) 927-933.
Brittan M, Hunt T, Jeffery R, Poulsom R, Forbes S, Hodivala-Dilke K, Alison M, Wright NA(2002). Bone marrow derivation of intestinal subepithelial myofibroblasts in the mouse and human small intestine and colon. GASTROENTEROLOGY vol. 122, (4) A95-A96.
Forbes SJ, Hunt T, Brittan M, Jeffery R, Poulsom R, Hodivala-Dilke K, Alison MR, Wright NA(2002). Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. GUT vol. 50, A35-A35.
Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO et al.(2002). Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med vol. 8, (1) 27-34.
Hodivala-Dilke K(2002). Primary mouse keratinocyte culture. Methods Mol Biol vol. 188, 139-144.
Hynes RO, Lively JC, McCarty JH, Taverna D, Francis SE, Hodivala-Dilke K, Xiao Q(2002). The diverse roles of integrins and their ligands in angiogenesis. Cold Spring Harb Symp Quant Biol vol. 67, 143-153.
Poulsom R, Forbes SJ, Hodivala-Dilke K, Ryan E, Wyles S, Navaratnarasah S, Jeffery R, Hunt T et al.(2001). Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol vol. 195, (2) 229-235.
Forbes SJ, Wyles SM, Ryan ED, Navaratnarasah S, Hodivala-Dilke KM, Jeffrey R, Hunt T, Alison MR et al.(2001). Kidney from bone marrow in humans and mice. J PATHOL vol. 195, 3A-3A.
Forbes SJ, Alison MR, Hodivala-Dilke KM, Jeffery R, Poulsom R, Wright NA(2001). Bone marrow stem cells make hepatocytes with replicative potential. GASTROENTEROLOGY vol. 120, (5) A62-A62.
Forbes SJ, Hodivala-Dilke KM, Jeffery R, Alison MR, Poulsom R, Thomas H, Wright NA(2001). Hepatocytes derived from bone marrow stem cells demonstrate polyploidisation. J HEPATOL vol. 34, 20-21.
Forbes SJ, Hodivala-Dilke KM, Jeffery R, Hunt T, Alison MR, Poulsom R, Wright NA(2001). Hepatocytes derived from bone marrow stem cells show polyploidization in humans and mice. GUT vol. 48, A65-A66.
Lively JC, Hodivala-Dilke K, Hynes RO(2000). In vitro characterization of integrin-deficient endothelial cells and aortic explants. MOL BIOL CELL vol. 11, 51A-51A.
McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, Novack D, Feng X, Ross FP et al.(2000). Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest vol. 105, (4) 433-440.
Hynes RO, Hodivala-Dilke KM(1999). Insights and questions arising from studies of a mouse model of Glanzmann thrombasthenia. Thromb Haemost vol. 82, (2) 481-485.
Hynes RO, Bader BL, Hodivala-Dilke K(1999). Integrins in vascular development. Braz J Med Biol Res vol. 32, (5) 501-510.
Tsakiris DA, Scudder L, Hodivala-Dilke K, Hynes RO, Coller BS(1999). Hemostasis in the mouse (Mus musculus): a review. Thromb Haemost vol. 81, (2) 177-188.
Hodivala-Dilke KM, McHugh KP, Tsakiris DA, Rayburn H, Crowley D, Ullman-Culleré M, Ross FP, Coller BS et al.(1999). Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest vol. 103, (2) 229-238.
Hodivala-Dilke KM, DiPersio CM, Kreidberg JA, Hynes RO(1998). Novel roles for alpha3beta1 integrin as a regulator of cytoskeletal assembly and as a trans-dominant inhibitor of integrin receptor function in mouse keratinocytes. J Cell Biol vol. 142, (5) 1357-1369.
DiPersio CM, HodivalaDilke KM, Jaenisch R, Kreidberg JA, Hynes RO(1997). alpha 3 beta 1 integrin is required for normal development of the epidermal basement membrane. J CELL BIOL vol. 137, (3) 729-742.
Braga VM, Hodivala KJ, Watt FM(1995). Calcium-induced changes in distribution and solubility of cadherins, integrins and their associated cytoplasmic proteins in human keratinocytes. Cell Adhes Commun vol. 3, (3) 201-215.
Watt FM, Hodivala KJ(1994). Cell adhesion. Fibronectin and integrin knockouts come unstuck. Curr Biol vol. 4, (3) 270-272.
Hodivala KJ, Pei XF, Liu QY, Jones PH, Rytina ER, Gilbert C, Singer A, Watt FM(1994). Integrin expression and function in HPV 16-immortalised human keratinocytes in the presence or absence of v-Ha-ras. Comparison with cervical intraepithelial neoplasia. Oncogene vol. 9, (3) 943-948.
Hodivala KJ, Watt FM(1994). Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation. J Cell Biol vol. 124, (4) 589-600.
Billingsley PF, Hodivala KJ, Winger LA, Sinden RE(1991). Detection of mature malaria infections in live mosquitoes. Trans R Soc Trop Med Hyg vol. 85, (4) 450-453.
Suhrbier A, Winger L, O'Dowd C, Hodivala K, Sinden RE(1990). An antigen specific to the liver stage of rodent malaria recognized by a monoclonal antibody. Parasite Immunol vol. 12, (5) 473-481.
Winger L, Suhrbier A, O'Dowd CA, Hodivala KJ, Sinden RE(1990). A liver-stage specific antigen of P. berghei identified by a monoclonal antibody. Bull World Health Organ vol. 68 Suppl, 172-177.
Sinden RE, Suhrbier A, Davies CS, Fleck SL, Hodivala K, Nicholas JC(1990). The development and routine application of high-density exoerythrocytic-stage cultures of Plasmodium berghei. Bull World Health Organ vol. 68 Suppl, 115-125.
Suhrbier A, Wiser MF, Winger L, Harte P, Newton MF, Hodivala KJ, Nicholas J, Sinden RE(1989). Contrasts in antigen expression in the erythrocytic and exoerythrocytic stages of rodent malaria. Parasitology vol. 99 Pt 2, 165-170.
Return to top